Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator-the EVADEF study

Because of ICD efficiency, progressive HF is the main cause of death within 2 years of implant, although these patients are only mildly symptomatic at implantation. In addition to optimal pharmacologic therapy, these results raise the question of systematically implanting ICDs with cardiac resynchronization therapy in patients with electrical asynchronism at baseline.